Article
Hypercapnia limits β-catenin-mediated alveolar type 2 cell progenitor function by altering…
medRxiv · 2022 · Dada, L. A.; Welch, L. C.; Magnani, N. D.; Ren, Z.; Brazee, P. L.; Celli, D.; Flozak, A. S.; Weng, A.; Maciel-Herrerias, M.; Kryvenko, V.; Vadasz, I.; Runyan, C. E.; Abdala-Valencia, H.; Shigemura, M.; Casalino-Matsuda, S. M.; Misharin, A. V.; Budinger, G. R. S.; Gottardi, C. J.; Sznajder, J. I.
Key facts
| Title | Hypercapnia limits β-catenin-mediated alveolar type 2 cell progenitor function by altering Wnt production from adjacent fibroblasts |
|---|---|
| First author | Dada, L. A.; Welch, L. C.; Magnani, N. D.; Ren, Z.; Brazee, P. L.; Celli, D.; Flozak, A. S.; Weng, A.; Maciel-Herrerias, M.; Kryvenko, V.; Vadasz, I.; Runyan, C. E.; Abdala-Valencia, H.; Shigemura, M.; Casalino-Matsuda, S. M.; Misharin, A. V.; Budinger, G. R. S.; Gottardi, C. J.; Sznajder, J. I. |
| Journal | medRxiv |
| Published | Jan 13, 2022 |
| DOI | 10.1101/2022.01.12.475264 |
| Devices mentioned | BK110039, K103302, K973350, K990827 |
| Product codes mentioned | JJH, JJQ, JQW, KIT, MVU, NDS, NJT, OOI, PFF, PFT, QKO, JLX and 2 more |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1